Stryker Gross Margin 2010-2024 | SYK
Current and historical gross margin for Stryker (SYK) over the last 10 years. The current gross profit margin for Stryker as of June 30, 2024 is %.
| Stryker Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-06-30 | $21.39B | $13.61B | 63.63% |
| 2024-03-31 | $20.96B | $13.38B | 63.80% |
| 2023-12-31 | $20.50B | $13.06B | 63.70% |
| 2023-09-30 | $19.89B | $12.59B | 63.32% |
| 2023-06-30 | $19.46B | $12.22B | 62.79% |
| 2023-03-31 | $18.95B | $11.86B | 62.58% |
| 2022-12-31 | $18.45B | $11.58B | 62.76% |
| 2022-09-30 | $17.95B | $11.39B | 63.44% |
| 2022-06-30 | $17.63B | $11.25B | 63.80% |
| 2022-03-31 | $17.43B | $11.19B | 64.22% |
| 2021-12-31 | $17.11B | $10.97B | 64.11% |
| 2021-09-30 | $16.67B | $10.64B | 63.83% |
| 2021-06-30 | $16.25B | $10.46B | 64.38% |
| 2021-03-31 | $14.72B | $9.24B | 62.75% |
| 2020-12-31 | $14.35B | $9.06B | 63.11% |
| 2020-09-30 | $14.22B | $9.04B | 63.59% |
| 2020-06-30 | $14.07B | $8.91B | 63.34% |
| 2020-03-31 | $14.96B | $9.74B | 65.15% |
| 2019-12-31 | $14.88B | $9.70B | 65.14% |
| 2019-09-30 | $14.55B | $9.45B | 64.95% |
| 2019-06-30 | $14.20B | $9.27B | 65.29% |
| 2019-03-31 | $13.88B | $9.08B | 65.47% |
| 2018-12-31 | $13.60B | $8.94B | 65.72% |
| 2018-09-30 | $13.28B | $8.72B | 65.71% |
| 2018-06-30 | $13.04B | $8.55B | 65.58% |
| 2018-03-31 | $12.73B | $8.35B | 65.62% |
| 2017-12-31 | $12.44B | $8.18B | 65.73% |
| 2017-09-30 | $12.13B | $8.03B | 66.23% |
| 2017-06-30 | $11.96B | $7.92B | 66.26% |
| 2017-03-31 | $11.79B | $7.77B | 65.97% |
| 2016-12-31 | $11.33B | $7.50B | 66.26% |
| 2016-09-30 | $10.88B | $7.23B | 66.42% |
| 2016-06-30 | $10.47B | $6.98B | 66.67% |
| 2016-03-31 | $10.06B | $6.74B | 67.01% |
| 2015-12-31 | $9.95B | $6.60B | 66.38% |
| 2015-09-30 | $9.85B | $6.50B | 66.01% |
| 2015-06-30 | $9.82B | $6.44B | 65.56% |
| 2015-03-31 | $9.75B | $6.38B | 65.44% |
| 2014-12-31 | $9.68B | $6.36B | 65.70% |
| 2014-09-30 | $9.53B | $6.23B | 65.39% |
| 2014-06-30 | $9.29B | $6.14B | 66.08% |
| 2014-03-31 | $9.14B | $6.07B | 66.45% |
| 2013-12-31 | $9.02B | $6.02B | 66.72% |
| 2013-09-30 | $8.89B | $6.02B | 67.72% |
| 2013-06-30 | $8.79B | $5.95B | 67.66% |
| 2013-03-31 | $8.69B | $5.90B | 67.94% |
| 2012-12-31 | $8.66B | $5.88B | 67.88% |
| 2012-09-30 | $8.53B | $5.76B | 67.47% |
| 2012-06-30 | $8.51B | $5.72B | 67.23% |
| 2012-03-31 | $8.45B | $5.62B | 66.51% |
| 2011-12-31 | $8.31B | $5.50B | 66.16% |
| 2011-09-30 | $8.09B | $5.39B | 66.66% |
| 2011-06-30 | $7.82B | $5.26B | 67.18% |
| 2011-03-31 | $7.54B | $5.14B | 68.23% |
| 2010-12-31 | $7.32B | $5.03B | 68.77% |
| 2010-09-30 | $7.16B | $4.91B | 68.52% |
| 2010-06-30 | $7.04B | $4.79B | 68.04% |
| 2010-03-31 | $6.92B | $4.67B | 67.51% |
| 2009-12-31 | $6.72B | $4.54B | 67.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $139.112B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |